Mergers and acquisitions – was the Pfizer/AstraZeneca ‘no deal’ a success or failure?
There is something important to note about the deal on everyone’s lips at the time of writing (Pfizer/AstraZeneca). It is that journalists and politicians are repeating the ‘urban myth’ that `big pharma’ deals destroy value. This myth is proving difficult to dispel. Research conducted by Scott Moeller and myself for Intelligent M&A: Navigating the Mergers […]